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Acid sensing ion channels (ASICs) are proton-gated cation channels that are expressed throughout the
nervous system and have been implicated in mediating sensory perception of noxious stimuli. Amongst
the six ASIC isoforms, ASIC1a, 1b, 2a and 3 form proton-gated homomers, which differ in their activation
and inactivation kinetics, expression proﬁles and pharmacological modulation; protons do not gate
ASIC2b and ASIC4. As with many other ion channels, structure-function studies of ASICs have been
greatly aided by the discovery of some toxins that act in isoform-speciﬁc ways. ASIC3 is predominantly
expressed by sensory neurons of the peripheral nervous system where it acts to detect acid as a noxious
stimulus and thus plays an important role in nociception. ASIC3 is the only ASIC subunit that is inhibited
by the sea anemone (Anthopleura elegantissima)-derived toxin APETx2. However, the molecular mecha-
nism by which APETx2 interacts with ASIC3 remains largely unknown. In this study, we made a homology
model of ASIC3 and used extensive protein–protein docking to predict for the ﬁrst time, the probable sites
of APETx2 interaction on ASIC3. Additionally, using computational alanine scanning, we also suggest the
‘hot-spots’ that are likely to be critical for ASIC3–APETx2 interaction.
 2014 Elsevier Inc. All rights reserved.1. Introduction
Acid-sensing ion channels (ASICs) are voltage-insensitive,
proton-gated cation channels that belong to the epithelial sodium
channel (ENaC)/degenerin (DEG) family of ion channels. ASICs are
expressed in both the central and peripheral nervous system and,
due to their ability to respond to acidosis, they have been
implicated in nociception associated with inﬂammation and
ischemia [1].
Four genes encode six ASIC proteins (ASIC1a, 1b, 2a, 2b, 3 and 4;
the genes encoding ASIC1 and ASIC2 have splice variants that
produce a and b subtypes). Functional ASICs can be either homotri-
mers or heterotrimers, although neither ASIC2b nor ASIC4 form
functional homomers [2]. Subunit composition dictates numerous
channel properties including pH sensitivity, activation and inacti-
vation kinetics and pharmacological modulation [2]. Unlike ASIC1
and ASIC2, which are expressed throughout the nervous system,
ASIC3 expression is restricted largely to the periphery. Electro-
physiological evidence proposes that ASIC3 is a key candidate for
sensing the acidosis that occurs during episodes of myocardial
ischaemia and there is strong electrophysiological and behavioural
evidence for a role of ASIC3 in sensory mechanotransduction [3,4],although ASIC3 itself is not mechanosensitive [5,6]. In addition to
protons, endogenous, modulators of ASIC3 include the membrane
protein stomatin, which acts as a dimer to inhibit ASIC3 [7] and
agmatine, which causes sustained activation of ASIC3 at neutral
pH [8]. Structure function studies have been greatly aided by the
discovery of the ﬁrst peptide ligand of ASIC3 channels from the
toxin of the sea anemone Anthopleura elegantissima [9]. This toxin,
known as APETx2 is a 42 amino acid peptide that selectively blocks
ASIC3 homomeric channels as well as heteromeric ASIC2b+3,
ASIC1b+3, and ASIC1a+3 channels with decreasing afﬁnities [8].
Unlike toxins such as psalmotoxin 1 (PcTx1) and mambalgin 2,
which modulate ASIC1 subunits [10–13], little is known about
the precise binding site of APETx2 on ASIC3. In this work, we
sought to predict the possible site of interaction of APETx2 with
ASIC3 using extensive molecular modelling, protein–protein dock-
ing and computational alanine scanning mutagenesis.
2. Methods
2.1. Homology modelling of rASIC3
The homology model of homomeric rat ASIC3 (rASIC3, Uniprot
accession: O35240) was built using Modeller 9.11 [14] from the
1.9 Å crystal structure of chicken ASIC1 homotrimer (PDB id
2QTS) [15] as a template. Target and template sequences were
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ebi.ac.uk/Tools/msa/clustalw2/). Initially, 50 models of rASIC3
were generated and the best model was chosen based on the
DOPE score implemented within Modeller [14]. For the chosen
model, addition of missing hydrogen atoms and imposition of
protonation of histidine and acidic residues were done using the
program REDUCE [16]. The model was then embedded into a
pre-equilibrated membrane bilayer consisting of 128 molecules
of 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPC). The system
was then solvated in an octahedral box with TIP3P water mole-
cules and neutralized by adding NaCl up to 0.15 M. Afterwards
the system was energy-minimised by a round of steepest descent
minimisation followed by 500 steps of simulated annealing.
Finally, to relieve the rASIC3 model of any conformational strain
likely to be imposed by the template used, a 500 ps of unrestrained
MD simulation was carried out at 298 K in YASARA structure suite
(version 13.8.4, Yasara Biosciences GmbH, Austria) [17] using the
AMBER03 force ﬁeld [18]. Particle-mesh Ewald (PME) summation
[19] for the electrostatics was used for long-range Coulomb inter-
actions with a cut-off of 7.86 Å. Finally, the overall quality of
rASIC3 model was assessed using PROCHECK [20] and the ERRAT
server [21].
2.2. Preparation of the toxin structures
The structures of PcTx1 [22] and APET[2 were obtained from
the available NMR-derived structures (pdb ids 2KNI and 1WXN,
respectively) [23]. Further reﬁnement of the toxin structure was
made in the YASARA structure suit by side chain optimisation
and energy minimisation, keeping the backbone ﬁxed. Side chain
optimisation was performed using the SCWALL method [24] whilst
YAMBER2 force ﬁeld [25] was used for energy minimisation. After
removal of conformational stress by a short steepest descent min-
imisation, the procedure continued by simulated annealing (time
step 2 fs, atom velocities scaled down by 0.9 every 10th step) until
convergence was reached.
2.3. Optimisation of protein–protein docking protocol
Initially, several protein–protein docking servers were tried
and these include ClusPro 2.0 (http://cluspro.bu.edu), ZDOCK
(http://zdock.umassmed.edu), Hex (http://hexserver.loria.fr),
GRAMM-X 1.2.0 (http://vakser.bioinformatics.ku.edu/resources/
gramm/grammx/) and FTDock accessed through PyDockWeb
(http://life.bsc.es/servlet/pydock/home/). For judging the perfor-
mance the algorithms and scoring functions implemented in
these servers, a cognate blind-docking approach was used by
redocking of PcTx1 to chicken ASIC1a trimer and comparing the
output docked pose of the PcTx1 with the original pose present
in the crystal structure (pdb: 4FZ0) [11]. The ASIC1a low pH
structure (pdb: 4FZ0) was energy-minimised with the bound
PcTx1 removed. The algorithm (s) offering the least positional
difference (indicated by the root means squared deviation,
r.m.s.d value) between the docked and original PcTx1 structure
was considered the most reliable and thus was chosen for dock-
ing APETx2 onto rASIC3 model. The top ranked docked complex
was submitted to RosettaDock [26] for further reﬁnement. The
lowest-energy complex was chosen from the out-puts from
RosettaDock as the ﬁnal toxin-bound channel structure.
2.4. Other methods
Robetta server (http://robetta.bakerlab.org/) was used for the
computational alanine-scanning mutagenesis [27]. The electro-
static surface potential maps were generated using the AdaptivePoisson-Boltzmann Solver (APBS) [28]. All graphics were prepared
using PyMol.
3. Results
3.1. Quality of the homology model
As most of the experimental studies of APETx2-mediated
inhibition of ASIC3 channels have been conducted on rASIC3, we
considered this isoform for the present study. The rASIC3 model
(Fig. 1A) was broadly similar to the template cASIC1a (PDB 2QTS)
used. Individual chains superimpose well (r.m.s.d < 1.5 Å)
(Fig. 1B) on each other, which is unsurprising, given the consider-
able (64%) homology in their amino acid sequences. Trajectory
analysis following brief (500 ps) MD simulation of the mem-
brane-embedded rASIC3 model indicates that the structure largely
stabilized after 200 ps as evidenced by stability of the r.m.s.d val-
ues of the backbone atoms with respect to those of the starting
structure (Fig. 1C).
The rASIC3 model (Fig. 1B) used for the present work seemed to
have good stereo-chemical features when assessed by the
Ramachandran plot analysis. The result of this analysis (Fig. S1)
indicated 93.2% of rASIC3 residues were in the most favoured
regions, 5.4% was in an additionally allowed region, 1.4% was in
generously allowed region with none within the disallowed region.
The model was also assessed by ERRAT score, which gives an over-
all quality factor for non-bonded atomic interactions, and a score of
greater than 50 is acceptable [21]. The template cASIC1 and our
ﬁnal reﬁned model of rASIC3 yielded ERRAT scores of 87.40 and
72.05, respectively, and the values were well within the range of
high quality.
3.2. Protein–protein docking
To ﬁnd the best docking protocol for our protein partners, we
ﬁrst considered several web servers such as ZDOCK [29], ClusPro
2.0 [30], GRAMM-X 1.2.0 [31], Hex [32], PatchDock [33] and FTdock
accessed through PyDockWeb (http://life.bsc.es/servlet/pydock/
home/). Of these docking severs, ClusPro, GRAMM-X, ZDOCK and
FTdock exploit fast-Fourier transform methods for grid matching
whereas PatchDock relies on shape complementarity and symme-
try restrictions; and Hex is based on spherical harmonic represen-
tations [34]. To ﬁnd the best docking algorithm and scoring
function, we tried cognate, blind docking of PcTx1 to cASIC1, for
which known crystal structures exist, and we only considered
the top 10 output poses from each to the above mentioned web
servers. Among the latter, ZDOCK, ClusPro, FTdock and GRAMM-
X produced top ranked poses of PcTx1 that broadly lay within
similar region (r.m.s.d < 4 Å) found in the original crystal structure
(PDB id 4FZ0). However, in terms of the absolute proximity of the
docked pose with the original pose of PcTx1, ZDOCK proved to be
the best (r.m.s.d < 3 Å) (Fig. 2A) and we used ZDOCK for the initial
blind docking APETx2 on rASIC3 model. Since ZDOCK essentially
considers the interacting protein partners as rigid and thus
excludes the possibility of any structural rearrangement occurring
[29], we submitted the top ranked complex of PcTx1 and cASIC1
to the Rosetta protein–protein docking protocol [26] for further
reﬁnement. The RosettaDock server identiﬁes low-energy confor-
mations of a protein–protein complex near a given starting
conformation through optimisation of rigid-body orientation and
side-chain conformations [35]. Post-docking reﬁnement through
Rosetta docking resulted in signiﬁcant improvement in PcTx1 pose
as the distance between the docked structure to the original crystal
structure (calculated as r.m.s.d) signiﬁcantly reduced from 2.6 Å to
1.81 Å, thus reproducing almost an identical pose of PcTx1
(Fig. 2B). Thus, our ultimate docking protocol involved a fast, initial
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Fig. 1. Homology model of rASIC3. (A) Homology model of rASIC3 embedded in POPC lipid bilayer which was used for subsequent reﬁnement of the model. (B) Overall 3D
similarity between the template (cASIC1, shown in blue) and the ﬁnal rASIC3 model (shown in salmon pink) channels. (C) Conformational stability of the rASIC3 model
assessed in 500pS MD simulation. Y axis contains root mean squared deviations (r.m.s.d) of backbone atoms of the sampled conformations of rASIC3 model with respect to
those of the initial conformation. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 2. Validation of docking protocol by assessing the reproducibility of poses of psalmotoxin-1 (PcTx-1) binding to chicken ASIC1 (pdb 4FZ0). (A) Several protein–protein
docking methods tested and the best results were observed with ZDOCK which placed PcTx1 within close proximity (r.m.s.d 2.60 Å) to the original crystallized pose of the
toxin. (B) Subsequent reﬁnement of the crude ZDOCK pose through RosettaDock and signiﬁcant improvement of the pose was achieved as the distance between the docked
pose and the original crystal structure of the toxin further reduced (r.m.s.d 1.81 Å). In both cases, the redocked and the original crystallized poses of PcTx1 are shown as red
and blue, respectively. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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through RosettaDock.
In the top 10 ZDOCK poses, two major potential interacting sites
for APETx2 were identiﬁed on the rASIC3 homotrimeric model
(Fig. 3). Site A representing the highest ranked pose was withinthe upper ‘thumb’ area [36] of the extracellular domain of the
channel, whilst Site B representing the second best ranked pose
was between the ‘wrist’ and ‘palm’ regions, located above the tras-
membrane helices (Fig. 3A and B). Clustering of poses broadly on
these two sites was observed also with ClusPro, GRAMM-X and
site A
site B
A 
C 
site A
site B
B 
site Bsite A
Fig. 3. Possible sites for APETx2 interaction on rASIC3 dimer. (A) Two possible sites of APETx2 interaction on rASIC3 were predicted by ZDOCK followed by subsequent
reﬁnement with RosettaDock. Similar predictions were made by other protein–protein docking algorithms (not shown). (B) The two possible sites are shown in rASIC3 dimer
shown in surface representation. (C) The electrostatic surface potential representations of rASIC3 and docked APETx2 at site A and site B. Red, blue, and white represent acidic,
basic, and neutral (hydrophobic) regions, respectively with the sliding colour scale (±5 kTe1, where k is the Boltzmann constant, T is temperature and e is the elementary
charge) below indicating the charge distribution across the surfaces. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web
version of this article.)
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the two sites obtained through these servers varied. For example,
in FTdock and GRAMM-X, Site B was ranked top, whilst Site A
was second (not shown), whereas the reverse ranking was
observed with ZDOCK and ClusPro.
Molecular electrostatics surface potential calculation using the
APBS Solver [28] shows that both Site A and Site B on rASIC3 are
largely electronegative, indicating the predominance of acidic res-
idues within these regions (Fig. 3C). Similar analysis with APETx2
shows that the interface used by the toxin for docking on to rASIC3
at these sites is largely electropositive and electroneutral (Fig. 3C).
Next, we sought to map the key residues for the interaction
between rASIC3 and APETx2 for both these sites. For this, we ﬁrst
identiﬁed the residues that were within 5 Å distance of the docked
APETx2 pose at each site and then looked for the hot spots through
using the computational alanine scanning mutagenesis imple-
mented in the Robetta server [35]. Table 1 shows the proximal res-
idues of the interacting partners as well as the key residues that are
likely to form the hot spots for the interaction (i.e. for which DDG
was greater than 1 kcal/mol). For interaction at Site A, only F293 of
rASIC3 appears to be critical whilst for site B, two potential hot
spot residues – S82 and E426 are suggested. For interaction at both
sites, APETx2 seems to employ almost same group of residues,
which are largely hydrophobic.4. Discussion
In response to reduction of pH from physiological pH, the
current generated by ASIC3 is typically biphasic comprising of a
transient peak component followed by a slowly developing, sus-
tained component [7,37]. APETx2 rapidly and reversibly inhibits
the transient peak current and the sustained component evoked
at pH 7.0 [38], but it does not affect the sustained component at
pH 5.0 [9]. In several recent studies, APETx2 has also been shown
to inhibit the current mediated by certain voltage-gated sodium
channels with variable potencies [39,40]. In the present study we
focused only on APETx2 modulation of ASIC3 and found two poten-
tial candidate sites on rASIC3 via which APETx2 could exert its
effect. It is noteworthy that Site A is contained within the upper
palm region of each subunit in homomeric rASIC3 (and a human
ASIC3 model as well, data not shown). This is intriguing because
it implies that the presence of a single ASIC3 subunit could confer
some sensitivity towards inhibition by APETx2. Indeed, in addition
to APETx2 inhibiting both rat and human homomeric ASIC3 (IC50s
of 37–63 nM and 175 nM respectively), several (but not all)
ASIC3-containing heterotrimeric ASICs are inhibited with lower
potency [9,23,41,42]. Among the residues of rASIC3 that are within
the 5 Å distance to the docked APETx2 at Site A, only residue (F293)
residue came out as a hot-spot.
Table 1
Amino acids within the interface of rASIC3 and bound APETx2.
⁄The hotspot residues are shown in bold with corresponding DDG > 1 kcal/mol
given in parenthesis. The residues of rASIC3 and APETx2 were within 5 Å distance
from each other. The residues coloured in red are from different subunit.
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region [13], which is at an interface between adjacent subunits.
But only one subunit appears to contain the two predicted hot
spots – S82 and E426 for this site (Table 1).
Previously, Chagot and colleagues [23] noted that two clusters
of residues located on opposite faces of APETx2 were different from
APETx1: Cluster 1 (A3, S5, N8, K10, T39 and A41) and Cluster 2
(Y16, R17, P18, R31 and T36). APETx1 is known to inhibit hERG
channels, with no effect on ASIC3 and thus residues constituting
Cluster 1 and Cluster 2 of APETx2 were proposed to be involved
in the interaction and inhibition of ASIC3. Indeed, Anangi et al.
[41] demonstrated that the single point mutation R17, which is
part of Cluster 2, resulted in much reduced inhibition of mouse
ASIC3 current. Furthermore, Jensen and colleagues [42] found that
inhibition of ASIC3 by APETx2 was substantially reduced when the
N- and C-termini were joined through a peptide linker and also for
some N- or C-terminally truncated mutants; truncation mutants at
the N terminus showed the highest (300-fold) reduction in ASIC3
inhibition. It was thus suggested that residues in the APETx2 N-ter-
minus and some from Cluster 2 (Y16, R17, P18, R31 and/or T36) are
essential components of the pharmacophore that mediates APETx2
interaction with ASIC3. It is noteworthy that many of the residues
of docked APETx2 within 5 Å of Site A and Site B of rASIC3 model
(Table 1) in our study overlap with those suggested by Chagot
and colleagues [23] and more recently by Jensen et al. [42]. More-
over, R17, which has been reported to be critical for association ofAPETx2 and mouse ASIC3, came out as a hot spot only for the Site B
pose of APETx2.
Based entirely on docking and clustering of poses, both Site A
and Site B remain plausible sites for APETx2 interaction with ASIC3
and Site A was ranked top when ZDOCK was used. However,
several observations from published work seem to favour Site B
as the preferred one. For example, Site A is located near the upper
‘palm’ region that in ASIC1 remains effectively unchanged at
variable pH and in toxin bound structures [13]. Furthermore, Site
A is also located more towards the channel periphery, and quite
further from the central vestibule and the ion-conduction pathway.
Whether interaction at this site, perhaps allosterically, could cause
the robust block of ASIC3 current by APETx2 demands experi-
ments. Site B, on the other hand, lie just above the ‘wrist’ region
that has been reported to be ﬂexible and altered by two toxins
(PcTx1 and Mit-Tx) that modulate the pore opening of ASIC1
[13,43]. Among other hot spots, APETx2 appears to use R17 to
interact with Site B only; previously this residue was found to be
a critical determinant of APETx2 inhibition of ASIC3 [41]. Finally,
it is also intriguing to note that certain hot spots within Site B,
namely S82 and E426 are proximal to residues implicated in
sensing non-proton ligands of ASIC3 [44]. All these factors would
indicate that of the two sites, interaction at Site B is more likely
to affect channel gating and ion permeation properties. The dem-
onstration of whether Site A or Site B is more important for APETx2
inhibition of ASIC3 must be determined through electrophysiolog-
ical analysis.
5. Conclusions
In conclusion, we have presented a model of rASIC3 and
proposed for the ﬁrst time, two possible sites for APETx2 interac-
tion and also speculated the relative plausibility of these sites.
Additionally, through computational alanine scanning mutagene-
sis, we identiﬁed some residues that may serve as ‘hot-spots’ for
such association at these sites. Our predictive ﬁndings should
guide future mutagenesis and functional studies for mapping the
actual APETx2 interaction site on ASIC3.
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